Evonile Pharma Board to Consider Rights Issue on 8th Oct'26
Novartis India Ltd · Intimation · 08 Oct 2026, 5:30 am
Evonile Pharma Board to Consider Rights Issue on 8th Oct'26 Evonile Pharma Limited (formerly Novartis India Limited) announced that its Board of Directors is scheduled to meet on 8th Oct'26 to consider raising funds via a rights issue of equity shares with a face value of ₹5 each to eligible equity shareholders. The proposed capital raise remains subject to board approval and requisite statutory clearances. Meanwhile, the company's trading window for designated persons remains closed from 1st Oct'26 until 5th Nov'26, covering both the rights issue discussion and the Q2 financial results declaration.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. · 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. · 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. · 05 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 · 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 · 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. · 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. · 04 Nov 2026
